Brgdar Ahmed, Yi Jin, Awan Ahmad, Taha Mohamed, Ogunti Richard, Gharbin John, Prafulla Mehrotra, Opoku Isaac
Internal Medicine, Howard University Hospital, Washington, DC, USA.
Cardiovascular Disease, Howard University Hospital, Washington, DC, USA.
Cureus. 2021 Dec 28;13(12):e20770. doi: 10.7759/cureus.20770. eCollection 2021 Dec.
Background Obstructive sleep apnea (OSA) is frequently seen with atrial fibrillation (AF) and is associated with increased cardiovascular morbidity, including hypertension, congestive heart failure, ischemic heart disease, and stroke. However, the impact of OSA on in-hospital outcomes of patients with AF is unclear. Methodology All patients aged ≥18 admitted primarily for AF between January 2016 and December 2017 were identified in the National Inpatient Sample database. They were then categorized into those with OSA and those without OSA. The primary outcome was in-hospital mortality. Unadjusted and adjusted analysis was performed on appropriate variables of interest. Results Of 156,521 primary AF hospitalizations, 15% of the patients had OSA. Baseline characteristics revealed no race disparity between the two groups. However, compared to those without OSA, the OSA group was younger and had a significantly higher proportion of males, obesity, heart failure, hypertension, chronic obstructive pulmonary disease, diabetes, and hyperlipidemia. Long-term anticoagulation and inpatient cardioversion were also higher in the OSA group. Following propensity matching, inpatient mortality was similar between the two groups [0.54% in OSA vs. 0.51% in non-OSA; adjusted odds ratio = 1.06 (95% confidence interval = 0.82-1.35)]. Similarly, OSA was not significantly associated with acute kidney injury, cardiac arrest, gastrointestinal bleed, acute stroke, or length of stay. However, the OSA group was less anemic and required fewer in-hospital blood transfusions. Conclusions Although OSA is highly prevalent in AF patients, inpatient mortality and cardiovascular outcomes such as cardiac arrest, stroke, or major bleeding were similar in AF patients with or without concomitant OSA with no significant differences in length of stay.
阻塞性睡眠呼吸暂停(OSA)常与心房颤动(AF)同时出现,并与心血管疾病发病率增加相关,包括高血压、充血性心力衰竭、缺血性心脏病和中风。然而,OSA对AF患者住院结局的影响尚不清楚。
在国家住院患者样本数据库中识别出2016年1月至2017年12月期间主要因AF入院的所有≥18岁患者。然后将他们分为有OSA组和无OSA组。主要结局是住院死亡率。对感兴趣的适当变量进行未调整和调整分析。
在156,521例原发性AF住院患者中,15%的患者患有OSA。基线特征显示两组之间无种族差异。然而,与无OSA患者相比,OSA组患者更年轻,男性、肥胖、心力衰竭、高血压、慢性阻塞性肺疾病、糖尿病和高脂血症的比例显著更高。OSA组长期抗凝和住院期间心脏复律的比例也更高。倾向匹配后,两组住院死亡率相似[OSA组为0.54%,非OSA组为0.51%;调整后的优势比=1.06(95%置信区间=0.82-1.35)]。同样,OSA与急性肾损伤、心脏骤停、胃肠道出血、急性中风或住院时间无显著关联。然而,OSA组贫血程度较轻,住院期间输血需求较少。
尽管OSA在AF患者中非常普遍,但伴有或不伴有OSA的AF患者住院死亡率和心血管结局(如心脏骤停、中风或大出血)相似,住院时间无显著差异。